Literature DB >> 17259697

Serum levels of calcification inhibition proteins and coronary artery calcium score: comparison between transplantation and dialysis.

Sandro Mazzaferro1, Marzia Pasquali, Francesco Pugliese, Giusi Barresi, Iacopo Carbone, Marco Francone, Daniela Sardella, Franco Taggi.   

Abstract

Vascular calcifications in CKD are now linked to serum alterations of both divalent ions and calcification inhibitory proteins. Due to possible biochemical differences between dialysis (D) and transplantation (Tx), we examined the entity and severity of these biochemical modifications and of coronary artery calcium score separately in these two populations. We assayed, besides standard markers of inflammation, divalent ions and serum levels of fetuin, matrix Gla protein (MGP) and osteoprotegerin (OPG), in 51 Tx patients (age 45 +/- 12 years; 30 males, 21 females; previous D duration 4.8 +/- 4.2 years; Tx since 6.6 +/- 5.5 years; Cr 1.8 +/- 0.6 mg/dl) and in 49 D patients (age 49 +/- 14 years; 30 males,19 females; D duration 5.6 +/- 4.8 years). Additionally, coronary calcium score (AS) was evaluated by cardiac multi-slice CT. Compared with D patients, Tx patients had better values of divalent ions and inflammation markers, and lower prevalence (65 vs. 86%; p < 0.02) and severity (AS = 570 +/- 1,637 vs. 1,311 +/- 3,128; p < 0.008) of coronary calcification. In addition, a tendency toward normalization for all of the three calcification inhibitory proteins was evident. In both Tx and D, AS correlated with age and OPG (Tx: r(s) = 0.439, p < 0.001, and r(s) = 0.510, p < 0.0001; D: r(s) = 0.471, p < 0.001, and r(s) = 0.403, p < 0.005, respectively); in D patients, a correlation was present also with D duration (r(s) = 0.435; p < 0.002), other markers of inflammation and, notably, fetuin (r(s) = -0.442; p < 0.002). Regression analysis selected previous time on D in Tx patients (r(m) = 0.400; p < 0.004), and C-reactive protein and OPG in D patients (r(m) = 0.518; p < 0.004) as the most predictive parameters of AS. Discriminant analysis confirmed the major role of age and D duration in the appearance of AS and evidenced male gender as a distinct risk condition. At variance, Tx duration was never associated with AS. In conclusion, as compared to D, renal Tx patients show serum levels of calcification inhibition proteins and of divalent ions closer to normal. As this is associated with a lower prevalence and severity of AS, it is suggested that Tx antagonize the accelerating role of D in the progression of vascular calcification. Assessment of both coronary calcifications and serum levels of calcification inhibitory proteins may be of value to identify those subjects at higher risk of development and progression of vascular lesions, among whom males have the highest rate. 2007 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17259697     DOI: 10.1159/000099095

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  11 in total

Review 1.  Vascular calcification in chronic kidney disease: Pathogenesis and clinical implication.

Authors:  Sinee Disthabanchong
Journal:  World J Nephrol       Date:  2012-04-06

2.  Lowering vascular calcification burden in chronic kidney disease: Is it possible?

Authors:  Sinee Disthabanchong
Journal:  World J Nephrol       Date:  2013-08-06

3.  Circulating calcification inhibitors and vascular properties in children after renal transplantation.

Authors:  Marieke J H van Summeren; Jeroen M Hameleers; Leon J Schurgers; Arnold P G Hoeks; Cuno S P M Uiterwaal; Thilo Krüger; Cees Vermeer; Wietse Kuis; Marc R Lilien
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

4.  Effects of bone and mineral metabolism on arterial elasticity in chronic renal failure.

Authors:  Eva Kis; Orsolya Cseprekál; Edina Bíró; Kata Kelen; Dóra Ferenczi; Andrea Kerti; Attila J Szabó; Antal Szabó; György S Reusz
Journal:  Pediatr Nephrol       Date:  2009-12       Impact factor: 3.714

5.  Progression of coronary artery calcification in renal transplantation and the role of secondary hyperparathyroidism and inflammation.

Authors:  Sandro Mazzaferro; Marzia Pasquali; Franco Taggi; Matteo Baldinelli; Carmina Conte; Maria Luisa Muci; Nicola Pirozzi; Iacopo Carbone; Marco Francone; Francesco Pugliese
Journal:  Clin J Am Soc Nephrol       Date:  2009-02-11       Impact factor: 8.237

Review 6.  Mineral metabolism and aging: the fibroblast growth factor 23 enigma.

Authors:  Beate Lanske; M Shawkat Razzaque
Journal:  Curr Opin Nephrol Hypertens       Date:  2007-07       Impact factor: 2.894

7.  Low bone volume--a risk factor for coronary calcifications in hemodialysis patients.

Authors:  Teresa Adragao; Johann Herberth; Marie-Claude Monier-Faugere; Adam J Branscum; Anibal Ferreira; Joao M Frazao; Jose Dias Curto; Hartmut H Malluche
Journal:  Clin J Am Soc Nephrol       Date:  2009-01-21       Impact factor: 8.237

8.  Vitamin k intake and plasma desphospho-uncarboxylated matrix Gla-protein levels in kidney transplant recipients.

Authors:  Paul Y Boxma; Else van den Berg; Johanna M Geleijnse; Gozewijn D Laverman; Leon J Schurgers; Cees Vermeer; Ido P Kema; Frits A Muskiet; Gerjan Navis; Stephan J L Bakker; Martin H de Borst
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

9.  Fetuin, matrix-Gla protein and osteopontin in calcification of renal allografts.

Authors:  Johan M Lorenzen; Filippo Martino; Irina Scheffner; Verena Bröcker; Holger Leitolf; Hermann Haller; Wilfried Gwinner
Journal:  PLoS One       Date:  2012-12-17       Impact factor: 3.240

10.  Osteoprotegerin inhibits calcification of vascular smooth muscle cell via down regulation of the Notch1-RBP-Jκ/Msx2 signaling pathway.

Authors:  Shaoqiong Zhou; Xin Fang; Xing Fang; Huaping Xin; Wei Li; Hongyu Qiu; Siming Guan
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.